EnvironmentGuru
Search
Search


Biology

Trending

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer s Disease
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer s Disease
Cambridge, MA, Mar 22, 2019 - (JCN Newswire) - Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) announced the decision to discontinue the global Phase 3 trials, ENGAGE and EMERGE, designed to evaluate the efficacy and safety of aducanumab i read more
Sniffing out Parkinson’s disease
Sniffing out Parkinson’s disease
Olfactory gift of retired nurse could lead to early Parkinson’s diagnosis technology The sense of smell is one of the least well understood of the senses. It has long been known that some dogs, and less commonly even humans, seem to be able to read more

Latest Bids

Wetland Restoration, Monarch Habitat Planting, Greene County, Indiana.(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This

Toxic Metal Nanoparticals in Electronic Cigarette Aerosol.The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health, Division of Laboratory Sciences (DLS), Tobacco and Volatiles Branch (TVB) intends to award a sole source

2019 JSOC Capability and Technology Interest Items and Planned Events.The Joint Special Operations Command (JSOC) has assembled two (2) versions of Special Operations Forces (SOF) Capability and Technology Interest Items: a SECRET listing and a subset at the

Announcement of Availability of Funds for Embryo Adoption/Donation Services and Public Awareness Grants.Funding Opportunity ID: 308953Opportunity Number: PA-EAA-19-001Opportunity Title:Announcement of Availability of Funds for Embryo Adoption/Donation Services and Public Awareness GrantsOpportunity

Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional.Funding Opportunity PAR-19-216 from the NIH Guide for Grants and Contracts. The goal of this program is to support the advancement of regulatory science to facilitate the implementation and the

Trending Jobs

There are no records for this query

Latest Events

Latest Awards

There are no records for this query

Recent Jobs

    There are no records for this query

Trending Events

There are no records for this query
Sniffing out Parkinson’s disease

Biology

Sniffing out Parkinson’s disease

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of

Biology

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of

There are no tags
Sniffing out Parkinson’s disease

Biology

Sniffing out Parkinson’s disease

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of

Biology

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of

China clones &Number 39 Sherlock Holmes&Number 39 police dog to cut

Biology

China clones &Number 39 Sherlock Holmes&Number 39 police dog to cut

ASAP Solid Phase Microextraction-Based Miniaturized Probe and Protocol for

Biology

ASAP Solid Phase Microextraction-Based Miniaturized Probe and Protocol for

ASAP In Vivo Measurement of Calcium Ion with Solid-State Ion-Selective

Biology

ASAP In Vivo Measurement of Calcium Ion with Solid-State Ion-Selective

ASAP In Vivo Two-Way Redox Cycling System for Independent Duplexed

Biology

ASAP In Vivo Two-Way Redox Cycling System for Independent Duplexed